
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.470 | 7.470 | 0.000 |
Shares | 93.450 | 93.450 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.478 | 18.341 |
Price to Book | 3.493 | 2.452 |
Price to Sales | 3.558 | 1.935 |
Price to Cash Flow | 14.515 | 11.671 |
Dividend Yield | 2.051 | 2.443 |
5 Years Earnings Growth | 9.209 | 12.540 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 89.680 | 8.490 |
Industrials | 5.440 | 22.395 |
Consumer Defensive | 4.880 | 9.517 |
Number of long holdings: 25
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Zhejiang Jolly Pharma | CNE100001096 | 7.93 | 15.92 | -6.46% | |
Hunan Fangsheng Pharm | CNE100001VG6 | 7.83 | 9.99 | -1.28% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 6.98 | 21.89 | -3.65% | |
Ningbo Sanxing Medical Electric | CNE100001567 | 5.08 | 26.22 | -0.64% | |
Xiamen Amoytop Biotech Co | CNE100003RT3 | 4.78 | 74.76 | -0.32% | |
Beijing New Oriental Star Petro Eng | CNE100001X92 | 4.65 | 18.54 | +1.98% | |
InventisBio | CNE100005Q22 | 4.60 | 21.58 | -3.70% | |
Humanwell Healthcare | CNE000000QW6 | 4.57 | 20.24 | -1.08% | |
Runben Biotechnology | CNE100006DK5 | 4.56 | 35.58 | +2.01% | |
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 4.50 | 86.03 | -3.48% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lord Value Advantage Stock Fund | 1.85B | -1.39 | -10.22 | 6.91 | ||
LACAM China Cyclical Strategy Equit | 746.94M | 0.00 | -8.49 | 7.70 | ||
Lord Growth Advantage Stock Fund | 193.48M | -2.19 | -7.77 | 4.73 | ||
Lord Theme Dynamic Asset Allocation | 8.88M | 6.02 | -5.20 | 3.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review